Compare TNDM & BXMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TNDM | BXMX |
|---|---|---|
| Founded | 2006 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2013 | N/A |
| Metric | TNDM | BXMX |
|---|---|---|
| Price | $25.14 | $13.68 |
| Analyst Decision | Buy | |
| Analyst Count | 18 | 0 |
| Target Price | ★ $28.33 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 124.9K |
| Earning Date | 04-29-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.24% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,014,736,000.00 | N/A |
| Revenue This Year | $8.01 | N/A |
| Revenue Next Year | $12.14 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.93 | N/A |
| 52 Week Low | $10.00 | $11.25 |
| 52 Week High | $29.65 | $15.00 |
| Indicator | TNDM | BXMX |
|---|---|---|
| Relative Strength Index (RSI) | 62.02 | 35.06 |
| Support Level | $19.66 | $13.32 |
| Resistance Level | $29.65 | $14.02 |
| Average True Range (ATR) | 1.21 | 0.21 |
| MACD | 0.20 | -0.08 |
| Stochastic Oscillator | 79.95 | 13.40 |
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Nuveen S&P 500 Buy-Write Income Fund is a diversified closed-ended management investment company based in the United States. Its investment objective is to seek attractive total returns with less volatility. The fund invests its managed assets in a diversified equity portfolio that seeks to substantially replicate price movements of the S&P 500 Index. It also uses an index options of writing index call options in seeking to moderate the volatility of returns relative to an all-equity portfolio. Its revenue is generated mainly from interest and dividend income.